Benzinga | Aug 10, 2020 07:08AM EDT

Chimerix Q2 EPS $(0.16) Beats $(0.17) Estimate, Sales $1.40M Beat $1.06M Estimate

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 54.29 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $1.40 million which beat the analyst consensus estimate of $1.06 million by 32.08 percent. This is a 2.64 percent decrease over sales of $1.44 million the same period last year.